Avid Bioservicesの空売り状況は、投資家がAvid Bioservicesの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Avid Bioservices (NASDAQ:CDMO) 株価情報, 空売り情報

Avid Bioservices

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

Avid Bioservices Inc

WIIM

United States Cellular shares are trading higher after the company announced an agreement with AT&T to sell a portion of its retained spectrum licenses for $1.018 billion.

News

Dividends

CCOI

Cogent Communications Raises Dividend From $0.985 To $0.995

PRTH

Priority Technology Holdings shares are trading higher after the company reported better-than-expected Q3 EPS and sales.

Turning Point Brands shares are trading higher after the company reported better-than-expected Q3 EPS and sales and raised its guidance.

<p><strong>Clear Channel Outdoor</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCO#NYSE">CCO</a>) released its Q3 earnings on Thursday, October 31, 2024 at 06:00 AM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Clear Channel Outdoor missed estimated earnings by 0.0%, reporting an EPS of $-0.06 versus an estimate of $-0.06.</p>
<p>Revenue was up $32.20 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>The company beat on EPS by $0.01 in the last quarter, resulting in a 3.0% drop share price change the following day.</p>
<p>Here's a look at Clear Channel Outdoor's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.06</td>
<td>-0.05</td>
<td>-0.17</td>
<td>0.04</td>
<td>-0.08</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.06</td>
<td>-0.04</td>
<td>-0.17</td>
<td>0.05</td>
<td>-0.11</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>557.41M</td>
<td>562.37M</td>
<td>478.55M</td>
<td>610.14M</td>
<td>594.92M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>558.99M</td>
<td>558.54M</td>
<td>481.75M</td>
<td>632.11M</td>
<td>526.79M</td>
</tr>
</tbody>
</table>
</p>
<h3>Latest Earnings Reports from Competitors</h3>
<p>With Clear Channel Outdoor's earnings data now available, it's crucial to gauge how its competitors, including PubMatic, TechTarget, and National CineMedia, have been performing.</p>
<ul>
<li>PubMatic's earnings announcement on August 08, 2024 exceeded expectations, with an actual EPS of $0.17 compared to the market's projected EPS of $-0.02, resulting in a 950.0% increase.</li>
<li>TechTarget's earnings on August 08, 2024 exceeded market projections, revealing an EPS of $0.42 compared to the estimated EPS of $0.4, resulting in a 5.0% increase.</li>
<li>National CineMedia announced earnings on November 05, 2024, revealing results below market expectations. Despite the market's anticipation of an EPS of $-0.03, National CineMedia's actual EPS was $-0.04, resulting in a -33.33% decrease compared to expectations.</li>
</ul>
<h3>Competitors Quarterly Earnings and Stock Performance Analysis</h3>
<p>In this detailed analysis, insights are provided into the market's response to the latest earnings releases of key competitors. It highlights the expected and announced earnings per share (EPS) for each company, along with their corresponding stock prices at the close of the announcement day and the open of the following trading day.</p>
<p>
<table>
<thead>
<tr>
<th><strong>Company Name</strong></th>
<th><strong>Date</strong></th>
<th style="text-align: right;"><strong>EPS Expected</strong></th>
<th style="text-align: right;"><strong>EPS Announced</strong></th>
<th><strong>EPS Change Percent</strong></th>
<th><strong>Stock Price At Close</strong></th>
<th><strong>Stock Price at Next Day Open</strong></th>
<th><strong>Price Change Percent</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Clear Channel Outdoor</td>
<td>October 31, 2024</td>
<td style="text-align: right;">-0.06</td>
<td style="text-align: right;">-0.06</td>
<td>0.0%</td>
<td>$1.47</td>
<td>$1.48</td>
<td>0.68%</td>
</tr>
<tr>
<td>PubMatic</td>
<td>August 08, 2024</td>
<td style="text-align: right;">-0.02</td>
<td style="text-align: right;">0.17</td>
<td>950.0%</td>
<td>$19.6</td>
<td>$13.82</td>
<td>-29.49%</td>
</tr>
<tr>
<td>TechTarget</td>
<td>August 08, 2024</td>
<td style="text-align: right;">0.40</td>
<td style="text-align: right;">0.42</td>
<td>5.0%</td>
<td>$29.02</td>
<td>$28.38</td>
<td>-2.21%</td>
</tr>
<tr>
<td>National CineMedia</td>
<td>November 05, 2024</td>
<td style="text-align: right;">-0.03</td>
<td style="text-align: right;">-0.04</td>
<td>-33.33%</td>
<td>$7.3</td>
<td>$7.35</td>
<td>0.68%</td>
</tr>
</tbody>
</table>
</p>
<h3>Comparative Study: Estimated vs. Actual Peer Revenues</h3>
<p>Below is a comparison of estimated and announced revenue figures for Clear Channel Outdoor's peers. This comparison gives insights into the revenue performance of these companies, providing valuable context for understanding their financial standing within the industry.</p>
<p>
<table>
<thead>
<tr>
<th><strong>Company Name</strong></th>
<th><strong>Estimated Revenue</strong></th>
<th><strong>Announced Revenue</strong></th>
<th><strong>Revenue Surprise Percentage</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Clear Channel Outdoor</td>
<td>557.41M</td>
<td>558.99M</td>
<td>0.28%</td>
</tr>
<tr>
<td>PubMatic</td>
<td>70.12M</td>
<td>67.27M</td>
<td>-4.07%</td>
</tr>
<tr>
<td>TechTarget</td>
<td>58.08M</td>
<td>58.91M</td>
<td>1.44%</td>
</tr>
<tr>
<td>National CineMedia</td>
<td>58.02M</td>
<td>62.40M</td>
<td>7.55%</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Clear Channel Outdoor <a href="https://www.benzinga.com/quote/CCO/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings

Clear Channel Outdoor Q3 Earnings Assessment

MTSI

MACOM Technology Solutions shares are trading higher after the company reported Q4 EPS in line with estimates and sales that beat expectations.

EPAM

EPAM Systems shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 guidance above estimates. Also, the company issued better-than-expected Q4 revenue guidance and Adj. EPS guidance with its midpoint above estimates.

<p>MoneyLion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ML#NYSE">ML</a>) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $0.20 by 225 percent.  The company reported quarterly sales of $135.466 million which beat the analyst consensus estimate of $135.208 million by 0.19 percent.  This is a 22.86 percent increase over sales of $110.258 million the same period last year.</p>


Earnings Beats

Earnings Misses

MoneyLion Q3 2024 GAAP EPS $(0.25) Misses $0.20 Estimate, Sales $135.466M Beat $135.208M Estimate

Hilton Grand Vacations shares are trading higher after the company reported Q3 EPS in line with estimates and sales that beat expectations.

<p>Compass Point  analyst Dominick Gabriele   upgrades AvidXchange Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDX#NASDAQ">AVDX</a>) from Neutral to Buy and raises the price target from $8 to $15.</p>


Upgrades

Price Target

Analyst Ratings

AVDX

Compass Point Upgrades AvidXchange Holdings to Buy, Raises Price Target to $15

General

VERO

Venus Concept Announces Expansion Of International Distribution Network With Index International In Taiwan And Quirugil In Colombia

<p>Needham  analyst Bernie McTernan   reiterates Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) with a Hold.</p>


Reiteration

LYFT

Needham Reiterates Hold on Lyft

<p>ParaZero Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRZO#NASDAQ">PRZO</a>) (the "Company" or "ParaZero"), an aerospace company focused on safety systems for defense and commercial drones and urban air mobility aircraft, recently announced that it has received a $187,000 purchase order from a U.S.-based Advanced Air Mobility (AAM) company in the aerial vehicle industry. This order, which was initially announced in September 2024, followed the successful completion of the advanced drone safety system customization project that the Company previously announced and marks another milestone for ParaZero in the growing air mobility sector.</p>
<p>The purchase order included preparations for serial production, as well as the delivery of an initial batch of systems, signifying the initiation of potential future large-scale manufacturing and deployment of ParaZero's cutting-edge drone safety solutions. This order also represents the final step in fulfilling the comprehensive project requirements for the client, who has been closely working with ParaZero to ensure the integration of ParaZero's innovative drone safety technologies.</p>
<p>The order followed a customization project that focused on integrating an innovative safety solution into the customer's manned aircrafts, which is designed for personal, private, military and logistical applications.</p>


Contracts

PRZO

ParaZero Secured $187,000 Purchase Order For Cutting-Edge Drone Safety Systems, Moving Closer To Mass-Production

Health Care

Financing

OFIX

Orthofix Medical Announced The Entry Into A New Credit Agreement Providing The Company With Up To $275M In A Senior-secured Term Loan With A 48-month Interest Only Period

<p>Needham  analyst Charles Shi   reiterates ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with a Hold.</p>


Needham Reiterates Hold on ARM Holdings

<p>Duke Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DUK#NYSE">DUK</a>) affirms FY2024 Adj EPS guidance from $5.85-6.10 to $5.85-6.10 vs $5.98 analyst estimate..</p>


Guidance

Duke Energy Affirms FY24 Adj EPS Guidance Of $5.85-$6.10 vs $5.98 Est

<p>Repare Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(0.83) by 2.41 percent.</p>


RPTX

Repare Therapeutics Q3 2024 GAAP EPS $(0.81) Beats $(0.83) Estimate, Cash, Cash Equivalents And Marketable Securities Were $179.4M, Expected To Fund Its Current Operational Plans Into The Second Half Of 2026

<p><strong>Fourth-Quarter and Full-Year 2024 Financial Outlook</strong></p>
<p>Guidance metrics are based on continuing operations.</p>
<p>The Company is providing guidance on tax expense due to the expected fluctuation of its quarterly tax rate, stemming from the deferred tax reserve matter previously disclosed in fourth-quarter 2022. Importantly, the reserve does not impact cash taxes. Some portion of the reserve may reverse in future periods.</p>
<p>The Company closed the sale of its U.S. Sheer Hosiery business on September 29, 2023. For the full year 2023, its U.S. Sheer Hosiery business generated $50 million of net sales and an operating loss of $(2) million.</p>
<p>For fiscal year 2024, which ends on December 28, 2024, the Company currently expects:</p>
<ul>
<li>Net sales from continuing operations of approximately $3.61 billion, which includes projected headwinds of approximately $50 million from last year's U.S. Sheer Hosiery divestiture and approximately $42 million from changes in foreign currency exchange rates. This represents an approximate 4% decrease as compared to prior year on a reported basis and an approximate 2% decrease on an organic constant currency basis.</li>
<li>GAAP operating profit from continuing operations of approximately $174 million.</li>
<li>Adjusted operating profit from continuing operations of approximately $417 million, which includes a projected headwind of approximately $8 million from changes in foreign currency exchange rates.</li>
<li>Pretax charges for restructuring and other action-related charges of approximately $243 million.</li>
<li>GAAP and Adjusted Interest expense of approximately $195 million, which reflects the pay down of debt from the use of net proceeds from the <i>Champion</i> sale and internal cash generation.</li>
<li>GAAP Other expenses of approximately $53 million, which includes approximately $10 million of accelerated amortization of debt issuance costs. Adjusted Other expenses of approximately $43 million.</li>
<li>GAAP and Adjusted Tax expense of approximately $40 million, which includes a net tax benefit primarily related to a release of certain tax reserves.</li>
<li>GAAP loss per share from continuing operations of approximately $(0.32).</li>
<li>Adjusted earnings per share from continuing operations of approximately $0.39.</li>
<li>Cash flow from operations of approximately $250 million.</li>
<li>Capital investments of approximately $50 million, consisting of approximately $40 million of capital expenditures and approximately $10 million of cloud computing arrangements. Per GAAP, capital expenditures are reflected in cash from investing activities and certain cloud computing arrangements are reflected in Other Assets within cash flow from operating activities. The approximate $10 million of cloud computing arrangements is factored into the full year cash flow from operations guidance of approximately $250 million.</li>
<li>Free cash flow of approximately $210 million.</li>
<li>Fully diluted shares outstanding of approximately 355 million.</li>
</ul>
<p>For fourth-quarter 2024, which ends on December 28, 2024, the Company currently expects:</p>
<ul>
<li>Net sales from continuing operations of approximately $900 million, which includes projected headwind of approximately $4 million from changes in foreign currency exchange rates. This represents an approximate 2% increase as compared to prior year on a reported basis and an approximate 3% increase on an organic constant currency basis.</li>
<li>GAAP operating profit from continuing operations of approximately $95 million.</li>
<li>Adjusted operating profit from continuing operations of approximately $115 million, which includes a projected headwind of approximately $1 million from changes in foreign currency exchange rates.</li>
<li>Pretax charges for restructuring and other action-related charges of approximately $20 million.</li>
<li>GAAP and Adjusted Interest expense of approximately $45 million, which reflects the pay down of debt from the use of net proceeds from the <i>Champion</i> sale and internal cash generation.</li>
<li>GAAP Other expenses of approximately $24 million, which includes approximately $10 million of accelerated amortization of debt issuance costs. Adjusted Other expenses of approximately $14 million.</li>
<li>GAAP and Adjusted Tax expense of approximately $5 million, which includes a net tax benefit primarily related to a release of certain tax reserves.</li>
<li>GAAP earnings per share from continuing operations of approximately $0.06.</li>
<li>Adjusted earnings per share from continuing operations of approximately $0.14.</li>
<li>Fully diluted shares outstanding of approximately 357 million.</li>
</ul>
<p>HanesBrands has updated its quarterly frequently-asked-questions document, which is available at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.Hanes.com%2FFAQ&amp;esheet=54148472&amp;newsitemid=20241107569107&amp;lan=en-US&amp;anchor=www.Hanes.com%2FFAQ&amp;index=1&amp;md5=b4b20882990d535ada47fa19da8098bf">www.Hanes.com/FAQ</a>.</p>


Hanesbrands Sees Q4 Adj. EPS $0.14 Vs $0.12 Est.; Net Sales Of ~$900M Vs $942.13M Est.; FY24 Adj. EPS $0.39 Vs $0.34	 Est.; Net Sales Of ~$3.61B Vs $3.6B Est.

Dynatrace shares are trading lower. The company reported Q2 financial results.

<p>XOMA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOMA#NASDAQ">XOMA</a>) reported quarterly losses of $(1.59) per share which missed the analyst consensus estimate of $(0.44) by 261.36 percent.  The company reported quarterly sales of $9.197 million which beat the analyst consensus estimate of $6.493 million by 41.65 percent.  This is a 1.01K percent increase over sales of $830.000 thousand the same period last year.</p>


XOMA

XOMA Q3 2024 GAAP EPS $(1.59) Misses $(0.44) Estimate, Sales $9.197M Beat $6.493M Estimate

An announcement from Avid Bioservices ( ($CDMO) ) is now available. Avid Bioservices, Inc. has reported a strong start to fiscal 2025 with first-qu...

Avid Bioservices Reports Growth and Strong Pipeline

Avid Bioservices, Inc. (CDMO) Q1 2025 Earnings Call Transcript

In a report released yesterday, Sean Dodge from RBC Capital maintained a Buy rating on Avid Bioservices (CDMO – Research Report), with a price targ...

RBC Capital Sticks to Its Buy Rating for Avid Bioservices (CDMO)

Avid Bioservices stock rallies 18% after reporting increased backlog

Avidity Biosciences: Good Prospects, But We Are A Little Late

Avid Bioservices ( ($CDMO) ) has shared an update. At Avid Bioservices' 2024 Annual Meeting, stockholders approved significant amendments to the 20...

Avid Bioservices' Strategic Shareholder and Governance Updates

16:55 EST Avid Bioservices (CDMO) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breakin...

Avid Bioservices trading halted, news pending

18:35 EST Avid Bioservices (CDMO) trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...

Avid Bioservices trading resumes

Avid Bioservices (CDMO), GHO Capital Partners LLP and Ampersand Capital Partners announced they have entered into a definitive merger agreement for...

GHO Capital / Ampersand Capital to acquire Avid Bioservices for $12.50 per share

RBC Capital downgraded Avid Bioservices (CDMO) to Sector Perform from Outperform with a price target of $12.50, up from $12, after the company anno...

Comments

Avid Bioservices

空売り

Avid Bioservices (NASDAQ:CDMO) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル